New York, July 19th (TradersHuddle.com) – Shares of Johnson and Johnson (NYSE:JNJ) are trading higher by +0.24% ahead of its quarterly earnings release. JNJ, the consumer health care products company maker of Tylenol and Sudafed is expected to release its quarterly results on July 20th.
Wall Street Analysts consensus calls for a profit of $1.21 a share on $15.77 billion revenue.
JNJ estimates have a range of $0.12 a share. The high estimate calls for profit of $1.28 a share and the low estimate is calling for a profit of $1.16 a share, a year ago for the quarter the company reported $1.15 a share.
Johnson & Johnson (NYSE:JNJ) manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, Tylenol, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world. The consumer healthcare products company was founded in 1886 and is based in New Brunswick, NJ.